Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + ketamine vs propofol + ketamine for pain and agitation
IRCT20141001019359N20Phase 3Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine, propofol and ketamine in pain and agitation (2 arms), sponsored by North Khorasan University of Medical Sciences. Primary endpoints: Pain intensity and Agitation level. Started Jan 2026; status: completed.
02
Drugs
dexmedetomidinepropofolketamine
03
Conditions
painagitation
Beyond the preview
Go deeper on IRCT20141001019359N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141001019359N20.